stockportfolio.pro
BioMarin Pharmaceutical Inc. Gross Profit 2008–2025
BioMarin Pharmaceutical Inc. (BMRN) annual gross profit by fiscal year, computed from SEC filings. Compound growth +14.7%/yr over 17 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $2.50B | 77.7% | +10.1% |
| FY 2024 | $2.27B | 79.7% | +20.5% |
| FY 2023 | $1.89B | 78.0% | +18.5% |
| FY 2022 | $1.59B | 76.0% | +15.8% |
| FY 2021 | $1.38B | 74.5% | +3.0% |
| FY 2020 | $1.34B | 71.8% | -0.6% |
| FY 2019 | $1.34B | 78.9% | +14.3% |
| FY 2018 | $1.18B | 78.9% | +9.7% |
| FY 2017 | $1.07B | 81.6% | +18.1% |
| FY 2016 | $907.23M | 81.2% | +23.0% |
| FY 2015 | $737.89M | 82.9% | +17.7% |
| FY 2014 | $627.02M | 83.7% | +36.3% |
| FY 2013 | $460.09M | 83.9% | +12.5% |
| FY 2012 | $408.89M | 81.7% | +14.4% |
| FY 2011 | $357.33M | 81.0% | +16.8% |
| FY 2010 | $305.98M | 81.3% | +18.3% |
| FY 2009 | $258.75M | 79.7% | +6.1% |
| FY 2008 | $243.98M | 82.3% | — |
Source: BioMarin Pharmaceutical Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for BioMarin Pharmaceutical Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBioMarin Pharmaceutical Inc. — frequently asked questions
What is BioMarin Pharmaceutical Inc.'s gross profit?
BioMarin Pharmaceutical Inc. (BMRN) reported gross profit of $2.50B for fiscal year 2025, per its SEC filings.
How has BioMarin Pharmaceutical Inc.'s gross profit changed over time?
Between fiscal 2008 and 2025, BMRN's gross profit grew at roughly 14.7% per year (compound annual rate), from $243.98M to $2.50B.
Where does this data come from?
Figures are computed from BioMarin Pharmaceutical Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.